2019
31. May
MagForce AG publishes Directors' Dealings
2019
10. May
MagForce AG publishes Directors' Dealings
2019
09. May
MagForce AG publishes Directors' Dealings
2018
08. August
MagForce AG announces successful capital increase of US subsidiary MagForce USA, Inc.
2018
17. May
MagForce AG publishes Directors' Dealings
2018
03. May
MagForce AG publishes Directors' Dealings
2018
14. February
MagForce AG publishes Directors' Dealings
2018
13. February
MagForce AG publishes Directors' Dealings
2018
10. February
MagForce USA receives approval from the FDA to conduct a clinical trial of NanoTherm® focal tumor ablation therapy for intermediate-risk prostate cancer
2017
27. October
MagForce AG publishes Directors' Dealings
2017
16. August
MagForce AG publishes Directors' Dealings
2017
16. August
MagForce AG publishes Directors' Dealings
2017
14. August
MagForce AG publishes Directors' Dealings
2017
08. August
Insider information: MagForce AG concludes financing agreement with the European Investment Bank
2017
28. June
Insider information: MagForce AG successfully places capital increase from authorized capital
2017
28. June
Insider information: MagForce AG approves capital increase from authorized capital, excluding subscription rights
2017
09. May
Magforce AG publishes Directors' Dealings
2017
05. May
MagForce AG publishes Directors' Dealings
2016
11. October
MagForce AG publishes Directors' Dealings
2016
06. October
MagForce AG publishes Directors' Dealings
2016
05. October
MagForce AG publishes Directors' Dealings
2016
30. September
MagForce AG publishes Directors' Dealings
2016
30. August
MagForce AG publishes Directors' Dealings
2016
09. August
MagForce AG publishes Directors' Dealings